01:59 PM EDT, 09/13/2024 (MT Newswires) -- Bicara Therapeutics (BCAX) shares were up more than 42% in recent Friday trading after the company's stock marked its Nasdaq debut at higher than the $18-per-share IPO price.

The company's shares were trading at $25.70 per share in recent trading after opening at $26.25.

The company, on late Thursday, said it is offering 17.5 million common shares in the IPO and has granted underwriters a 30-day option to purchase up to about 2.6 million additional shares.

The offering is expected to close on Monday.

Price: 25.65, Change: +7.65, Percent Change: +42.47